Bruns Tony, Stallmach Andreas
Medizinische Klinik III, Uniklinik RWTH Aachen, Pauwelsstr. 30, 52074, Aachen, Deutschland.
Klinik für Innere Medizin IV, Universitätsklinikum Jena, Am Klinikum 1, 07747, Jena, Deutschland.
Internist (Berl). 2022 Apr;63(4):349-366. doi: 10.1007/s00108-022-01277-0. Epub 2022 Mar 3.
Ascending cholangitis and pyogenic liver abscesses are acute febrile bacterial hepatobiliary diseases. Nowadays they frequently occur in patients with structural changes of the biliary system and are usually treated by a combination of interventional drainage procedures and antimicrobial therapy. While Gram-negative Enterobacterales were identified as major causes in the past, biliary tract interventions and antibiotic exposure have contributed to an increase in enterococcal species and extended spectrum beta-lactamase (ESBL)-producing Enterobacterales. When selecting an appropriate empirical treatment the treating internist must consider local and individual risk factors for antimicrobial resistance in addition to pharmacokinetic aspects and disease severity to reduce the likelihood of treatment failure.
急性胆管炎和化脓性肝脓肿是急性发热性细菌性肝胆疾病。如今,它们常见于胆道系统结构改变的患者,通常采用介入引流手术和抗菌治疗相结合的方法进行治疗。虽然过去革兰氏阴性肠杆菌科被认为是主要病因,但胆道介入手术和抗生素的使用导致肠球菌属以及产超广谱β-内酰胺酶(ESBL)的肠杆菌科细菌有所增加。在选择合适的经验性治疗方案时,主治内科医生除了要考虑药代动力学因素和疾病严重程度外,还必须考虑当地和个体的抗菌药物耐药风险因素,以降低治疗失败的可能性。